77 related articles for article (PubMed ID: 12962366)
1. The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia.
Galimberti S; Testi R; Guerrini F; Fazzi R; Petrini M
J Chemother; 2003 Aug; 15(4):374-9. PubMed ID: 12962366
[TBL] [Abstract][Full Text] [Related]
2. [The clinical significance of lung resistance-related protein gene (lrp), multidrug resistance-associated protein gene (mrp) and mdr-1/p170 expression in acute leukemia].
Zhao Y; Yu L; Lou F; Wang Q; Pu J; Zhou Q
Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):760-3. PubMed ID: 11798719
[TBL] [Abstract][Full Text] [Related]
3. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia.
Huh HJ; Park CJ; Jang S; Seo EJ; Chi HS; Lee JH; Lee KH; Seo JJ; Moon HN; Ghim T
J Korean Med Sci; 2006 Apr; 21(2):253-8. PubMed ID: 16614510
[TBL] [Abstract][Full Text] [Related]
5. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
[TBL] [Abstract][Full Text] [Related]
6. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance].
Zhang JB; Sun Y; Dong J; Liu LX; Ning F
Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885
[TBL] [Abstract][Full Text] [Related]
7. [Expression of lung resistance protein and multidrug resistance protein genes in bone marrow cells of acute leukemia patients and its clinical significance].
Chi ZH; Liu Z; Sun C; Zhao HG; Liu JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):472-5. PubMed ID: 14575539
[TBL] [Abstract][Full Text] [Related]
8. [Expression of LRP, MRP and MDR1 in non-small-cell lung cancer and its clinical significance].
Wang J; Liu X; Jiang W
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):304-7. PubMed ID: 11778556
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
10. [The expression of multiple drug resistance associated genes in ovarian cancer].
Cheng G; Zhu H; Sun L
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):87-90. PubMed ID: 11809106
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between expression of lung resistance-related protein gene or multidrug resistance-associated protein gene and prognosis in newly diagnosed acute leukemia].
Zhao Y; Yu L; Wang Q; Lou F; Pu J
Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):183-5. PubMed ID: 11940320
[TBL] [Abstract][Full Text] [Related]
12. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.
Ogretmen B; Barredo JC; Safa AR
J Pediatr Hematol Oncol; 2000; 22(1):45-9. PubMed ID: 10695821
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
15. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.
Chauhan PS; Bhushan B; Singh LC; Mishra AK; Saluja S; Mittal V; Gupta DK; Kapur S
Exp Mol Pathol; 2012 Feb; 92(1):44-9. PubMed ID: 22037714
[TBL] [Abstract][Full Text] [Related]
16. Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia.
El-Sharnouby JA; Abou El-Enein AM; El Ghannam DM; El-Shanshory MR; Hagag AA; Yahia S; Elashry R
J Oncol Pharm Pract; 2010 Sep; 16(3):179-88. PubMed ID: 19969624
[TBL] [Abstract][Full Text] [Related]
17. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
Michieli M; Damiani D; Ermacora A; Masolini P; Raspadori D; Visani G; Scheper RJ; Baccarani M
Br J Haematol; 1999 Feb; 104(2):328-35. PubMed ID: 10050716
[TBL] [Abstract][Full Text] [Related]
19. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
20. Assessment of drug resistance in acute myeloid leukemia.
Funato T; Harigae H; Abe S; Sasaki T
Expert Rev Mol Diagn; 2004 Sep; 4(5):705-13. PubMed ID: 15347263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
